Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$4,165,147
-$155,539 QoQ
Shares Held
26,577
-6.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#297
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penobscot Investment Management Company, Inc. holds $78,402,280 across 11 Drug Manufacturers - General names. NVS ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
77,452 | $19,490,021 | |
| 2 | LLY |
ELI LILLY & Co
|
12,634 | $15,153,599 | |
| 3 | JNJ |
Johnson & Johnson
|
55,938 | $14,206,573 | |
| 4 | AZN |
Astrazeneca PLC
|
60,174 | $11,410,193 | |
| 5 | AMGN |
Amgen Inc
|
16,503 | $5,976,066 | |
| 6 | NVS |
Novartis AG
This page
|
26,577 | $4,165,147 | |
| 7 | MRK |
Merck & Co., Inc.
|
31,382 | $4,032,587 | |
| 8 | PFE |
Pfizer Inc
|
79,410 | $1,912,192 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,165,147 | 26,577 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $4,320,686 | 28,286 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $3,903,926 | 28,316 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,631,372 | 28,317 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $3,118,064 | 25,767 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,872,505 | 25,767 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,356,556 | 24,217 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,871,703 | 24,967 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,636,694 | 24,767 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,789,697 | 18,502 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,823,214 | 18,057 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,483,896 | 14,568 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $365,798 | 3,625 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $374,900 | 4,075 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $369,683 | 4,075 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $309,739 | 4,075 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $344,459 | 4,075 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $357,580 | 4,075 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $356,439 | 4,075 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $341,431 | 4,175 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $462,586 | 5,070 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $668,452 | 7,820 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $802,182 | 8,495 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $790,900 | 9,095 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $871,215 | 9,975 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $834,805 | 10,125 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||